Antibiotic resistance is generally associated with a fitness deficit resulting from the burden of producing and maintaining resistance machinery. This additional cost suggests that resistant bacteria will be outcompeted by susceptible bacteria in conditions without antibiotics. However, in practice this process is slow due in part to regulation that minimizes expression of these genes in the absence of antibiotics. This suggests that if it were possible to turn on their expression, the cost would increase, thereby accelerating removal of resistant strains. Experimental and theoretical studies have shown that environmental chemicals can change the fitness cost associated with resistance and therefore have a significant impact on population dynamics. MarA (multiple antibiotic resistance activator) is a clinically important regulator in Escherichia coli which activates downstream genes to increase resistance against multiple classes of antibiotics. Salicylate is an inducer of MarA which can be found in the environment and de-represses marA's expression. In this study, we sought to unravel the interplay between salicylate and the fitness cost of MarA-mediated antibiotic resistance. Using salicylate as a natural inducer of MarA, we found that a wide spectrum of concentrations can increase burden in resistant strains compared to susceptible strains. Induction resulted in rapid exclusion of resistant bacteria from mixed populations of antibiotic resistant and susceptible cells. A mathematical model captures the process and predicts its effect in various environmental conditions. Our work provides a quantitative understanding of salicylate exposure on the fitness of different MarA variants, and suggests that salicylate can lead to selection against MarA-mediated resistant strains. More generally, our findings show that natural inducers may serve to bias population membership and could impact antibiotic resistance and other important phenotypes.
Introduction
Antibiotic resistance is frequently associated with fitness deficits such as those resulting from burdensome expression of resistance proteins or from excessive energy consumption by resistance machinery (1) (2) (3) (4) (5) . These observations suggest that in the absence of antibiotic pressure, a bacterial population should be biased away from drug resistance (6) (7) (8) . In practice, compensatory mutations and precise regulation of burdensome protein expression reduce the effective cost, largely eliminating the fitness differences. For example, in an antibiotic-free environment, tetracycline resistant bacteria that express the costly TetA efflux pump are expected to be outcompeted by susceptible strains (9) . However, experiments have shown that the fitness cost of tetracycline resistance without antibiotic pressure is minimal (7, 10) . Tight repression of tetA by TetR keeps costs low in the absence of inducers (7, 9) . These regulatory approaches to reducing cost are common, and other examples include repression of the multiple antibiotic resistance activator marA by MarR (11) and the multi-drug efflux pump acrAB by AcrR (12) . However, certain environmental chemicals can serve as inducers that relieve repression, and may change the fitness of antibiotic resistant bacteria.
Environmental inducers include both the substrates that these mechanisms protect against (e.g. antibiotics) and other compounds. For example, the tetracycline decay product anhydrotetracycline (aTc) (10) , which is found widely in soil and wastewater (13, 14) , significantly increases the fitness cost of tetracycline resistant cells by releasing repression by TetR. The presence of aTc will select against resistant cells in the absence of antibiotic pressure because TetA is costly, but provides no benefit (9, 10) . Other environmental chemicals such as food preservatives (15) and pharmaceutical products (1) can impose fitness disadvantages by inducing higher levels of expression of resistance genes, which may lead to their eventual loss. A recent study demonstrated this effect by growing E. coli for 2000 generations in the presence of benzoate, an inducer for multiple antibiotic resistance genes. The majority of benzoate-evolved strains acquired mutations in marA and its homolog rob, thereby lowering resistance against chloramphenicol and tetracycline (15) .
MarA is a clinically important antibiotic resistance regulator conserved across enteric bacteria (16) . It increases resistance levels by regulating over 40 downstream genes (17) (18) (19) (20) (21) (22) (23) , including multi-drug efflux pumps and porins (24, 25) . Activation of these genes is taxing, resulting in decreased growth and a reduced fraction of cells with elevated MarA in a mixed community (1, 3) . However, marA is under the control of its repressor MarR, which minimizes the cost in the absence of induction (21) . MarA can also be modulated by its environmental inducer salicylate (1, 17) , which binds directly with MarR and prevents repression of marA (16) , significantly decreasing growth (1) , which suggests an intriguing interplay between this environmental inducer and the cost of antibiotic machinery.
In this work, we focused on the cost of MarA-mediated resistance under salicylate exposure. We found that a wide range of concentrations of salicylate can induce MarA-mediated burden. AcrAB-TolC efflux pumps were found to be a major contributor to the salicylate-induced burden. The difference in cost under salicylate exposure leads to rapid exclusion of resistant strains in competitive settings. A mathematical model captures the process by which populations are biased away from resistance and predicts its effect in various salicylate conditions. This work suggests that the fitness cost of MarA-mediated antibiotic resistance can be amplified by salicylate, biasing populations towards susceptible strains.
Materials and Methods

Strains
We used four strains in this research: WT, MarA -, MarA + , and AcrB -. In the MarAstrain, we deleted the marRAB operon, rob gene, and soxSR genes in E. coli MG1655 (26) . In the MarA + strain, we performed transversion mutations on MarR binding sites (23) in the chromosomal marRAB promoter to inhibit binding of MarR to the promoter region in E. coli MG1655 (26) . Further details on the deletion and transversion strains are given in Ref. (26) . The AcrBstrain was derived from the Keio collection JW0451 (BW25113 Δ acrB::kan) and we removed the kanamycin resistance marker following the protocol in Ref. (27) . For strains where we inserted the chromosomal fluorescent protein marker, we replaced the galK gene with sfgfp driven by a strong constitutive promoter.
Minimum inhibitory concentration
Overnight cultures of WT, MarA -, MarA + , and AcrBwere diluted 1:100 in LB medium. Diluted cultures were incubated at 37°C with 200 rpm shaking for 4 hours. Cells were then incubated with carbenicillin (0 to 50 μ g/ml in 2-fold dilutions) at 37°C for 24 hours with 200 rpm shaking. The minimum inhibitory concentration was determined as the concentration of antibiotic where no visible growth was observed.
Bacterial growth conditions
For all growth experiments, overnight cultures inoculated from a single colony were diluted 1:500 in LB medium. The diluted cultures were then pre-cultured for 3 hours at 37°C with shaking at 200 rpm. We refer to the end of this pre-culture as time point t = 0 hours. Salicylate was added at t = 0 hours when required, we then continued culturing at 37°C with 200 rpm shaking. OD 660nm readings were taken using a BioTek Synergy H1m plate reader each hour.
Competition experiments
For the competition experiments, each of two strains were cultured overnight separately, then diluted 1:1000 in fresh LB medium. Competition co-cultures were created by mixing cultures of each of two strains together in equal proportion. Co-cultures were then precultured for 3 hours, then at t = 0 salicylate was added where required, as in Ref. (1) . OD 660nm readings were taken each hour using the plate reader. In addition, immediately following OD 660nm measurements, 5 μ l of the sample was diluted into 200 μ l sterile phosphate-buffered saline (PBS) and we measured fluorescent protein expression with a Guava easyCyte HT flow cytometer. Flow cytometry data were analyzed with custom Matlab scripts. Control experiments using strains without green fluorescent protein expression were carried out to determine the threshold for strain classification (Fig. S1 ).
Antibiotic killing experiments
Cultures for antibiotic killing experiments were created by diluting overnight cultures of each of the strains at the percentages shown in Fig. 4 . Overnight cultures of each strains were first diluted 1:1000 in fresh LB medium, pre-cultured for 3 hours at 37°C with 200 rpm shaking, then strains were mixed together at percentages as specified in the figure axis. 50 μ g/ml of carbenicillin was then added to the co-cultures at t = 0. OD 660nm readings were taken using the plate reader four hours after carbenicillin exposure to determine antibiotic killing. Cells were then centrifuged and resuspended in PBS to wash out the antibiotics. Washed cultures were diluted and plated on LB agar for 24 hours in order to determine the number of colony-forming units after antibiotic exposure.
Dose-response experiments
Overnight cultures of the WT strain were diluted 1:50 in LB medium with 0, 0.6, 1.2, and 5mM salicylate. Diluted cultures with various concentration of salicylate were then pre-cultured for 3 hours at 37°C with 200 rpm shaking. Cells were then incubated with carbenicillin (0 to 50 μ g/ml in 2-fold dilutions) at 37°C for 4 hours with 200 rpm shaking. OD 660nm readings were taken using the plate reader four hours after carbenicillin exposure to determine cell density.
marA and acrAB transcriptional reporters
We used marA and acrAB transcriptional reporters in the WT strain to measure their transcriptional activity upon salicylate exposure. As described in Ref. (28) , the promoter region of each gene was cloned upstream of the gene for cyan fluorescent protein (cfp) on a low-copy (SC101 origin) plasmid. Salicylate was added at t = 0. The reporter fluorescence level was measured using microscopy after 3 hours of salicylate exposure. Fluorescence distributions were calculated using kernel density.
Gompertz model
All growth curves were fitted to the modified Gompertz model (Eq. 1) described in Ref. (29) . Carrying capacity (A), growth rate (μ), and lag-time (λ) were determined by least-squares fitting to the mean of the experimental data using a custom Matlab script.
Selection coefficient
The selection coefficients were calculated using the regression model (Eq. 2) described in Ref.
(30) after 4 hours of competition with or without exposure to salicylate.
S is the selection coefficient; R(t) is the final competition ratio of mutants to the WT strain, R(0) is the initial competition ratio of mutants to WT strain; t is number of generations in the competition experiment, corresponding to the number of doublings of OD 660nm observed (31) .
Lotka-Volterra model
The modified Lotka-Volterra equations (Eqs. 3 & 4) from Ref. (32) were used to simulate competitive growth in the co-culture:
N i is the cell density of strain i, μ i is the maximum growth rate, A i is the carrying capacity, α is the interaction matrix. We assumed no interaction between strains, α = 1. Both μ i and A i were determined using single strain experimental growth curve data fit to the Gompertz model, as described above. Long-time simulations for Fig. 5 assume dilution every 8 generations to the initial cell density, modeling serial transfers. We assume that the generation time is 30 minutes in the laboratory environment. All simulations were conducted using custom Matlab scripts.
Results and Discussion
MarA-mediated antibiotic resistance is costly
In order to investigate MarA-mediated resistance, we employed three strains of E. coli: one where MarA and its homologs Rob and SoxS are knocked out (denoted MarA -) (33), wild type (WT), and a strain where MarA is over-expressed via mutations in the MarR binding sites on its own promoter (MarA + ). To verify that these strains exhibit differences in antibiotic resistance, we first measured the minimum inhibitory concentration (MIC) of carbenicillin. As expected, we found that the MIC increases as MarA expression levels increase ( Fig. S2 ).
To quantify the cost of MarA-mediated resistance, we measured the growth of MarA -, WT, and MarA + strains in LB medium without antibiotics and used fits to the Gompertz model (Eq. 1) to extract parameters associated with growth from the data: growth rate (µ), lag time (ߣ), and carrying capacity (A) (29) (Fig. 1a ). We found that of the three model parameters only the growth rate was strongly dependent on MarA expression levels (Fig. 1b ), and effects on lag time and carrying capacity were minimal ( Fig. S3 ).
To evaluate whether these differences in growth rates could alter the proportion of bacteria with different MarA expression levels in a mixed population, we carried out competition assays between MarAand either WT or MarA + strains under antibiotic-free conditions (Fig. 1c) . To visualize the differences in the strains we integrated green fluorescent protein (sfgfp) into the genome of MarA -, and quantified the compositions of the mixed populations by flow cytometry (Methods, Fig. S1 ). With initially equal representation between the strains, we found that the MarAstrain outgrew MarA + but not WT in a short time window (4 h). In a longer competition (24 h), the MarAstrain outcompeted both WT and MarA + as expected due to the lack of burdensome MarA expression. The change in population composition is strongest between the antibiotic susceptible (MarA -) and antibiotic resistant (MarA + ) strains ( Fig. 1c ), suggesting fitness differentials are amplified if MarA is overexpressed. As a control, we also competed WT cells with and without genomically integrated sfgfp and found that the strains showed equal fitness, as expected (Fig. S4 ). The inverse relationship between MarA-mediated resistance and fitness supports the concept that differences in fitness cost could result in exclusion of resistant bacteria. 
Salicylate increases fitness cost in resistant strains compared to susceptible strains
Since MarA expression is costly, we reasoned that inducing its expression with salicylate should accelerate the process of biasing the population toward strains that lack MarA expression. To test this, we first measured expression from the marA promoter induced with various concentrations of salicylate (Fig. S5a ). Using transcriptional reporters for marA in WT cells, we observed a clear trend of increased expression as the salicylate concentration increased. We then measured the cost of MarA expression induced by salicylate. As expected, increasing salicylate dosages have a clear negative impact on the growth of WT cells ( Fig. 2a ). However, the salicylate growth reduction effect can also be observed in the MarAstrain (Fig. 2b) , which has marA and its homologs deleted. This suggests that salicylate can also reduce growth in a MarA-independent manner, possibly due to global effects such as by inhibiting expression of ATP synthase (34), decreasing membrane potential (35) , or reducing metabolic activity (26) .
Since salicylate can increase antibiotic resistance and decrease cell growth, in order to measure the costs and benefits of salicylate induction, we further measured the dose-response curve between carbenicillin and salicylate in the WT strain (Fig. S6 ). We observed a severe reduction in growth at high concentrations of salicylate in the absence of antibiotic, indicative of costs imposed by salicylate exposure. However, the cells have a growth benefit from salicylate induction when the carbenicillin concentration is high, suggesting a trade-off between benefits and costs of salicylate induction.
We next asked whether salicylate could increase the cost in strains with MarA expression (WT and MarA + ) relative to the MarAstrain. To do this, we compared the relative growth rates between MarAwith either WT or MarA + , measured by the ratio of the growth rates between the two strains in increasing concentration of salicylate (Fig. 2c) . Surprisingly, we found a weak positive correlation between relative growth rate and salicylate concentration in MarAvs. MarA + , but not in MarAvs. WT. Note that MarA + cannot respond to salicylate via the native repressor MarR due to mutations in its MarR binding sites, indicating that this response to salicylate involves factors beyond MarA overexpression, potentially through induction of the MarA homolog Rob (33) . We also observed similar effects using fitting to a Hill function (1) to quantify the growth cost in different strains as a function of salicylate concentration (Fig. S7 ). 
AcrAB-TolC efflux pump is a major contributor to MarA-mediated resistance burden
We next asked where the cost of salicylate-induced MarA burden was coming from. MarA regulates many downstream genes, but the AcrAB-TolC efflux pump is known to play a critical role in resistance and imposes a significant energy cost (3) . A transcriptional reporter for acrAB also showed that acrAB transcription can be induced by salicylate (Fig. S5b) . To test its role in salicylate-induced burden, we constructed AcrB -, an acrB knockout strain that renders the efflux pump nonfunctional. We also observed lower MIC values in AcrBcompared to WT or MarA + (Fig. S2 ).
We measured growth rate of AcrBwith MarA + and WT and compared it under various concentration of salicylate (Fig. 2b) . Interestingly, salicylate has only a modest effect on the growth rate of AcrBbelow 2.5 mM concentrations. We also observed a positive linear relationship between salicylate and the relative growth rate of AcrBwith WT and MarA + (Fig.  2c) . These results demonstrate that salicylate imposes less burden if the efflux pump is deleted. It is important to note that the AcrBstrain has intact copies of MarA and its homologs. Thus, AcrBcan still respond to salicylate exposure through MarA and its homologs, but the cost will not be increased in low salicylate concentrations if AcrAB-TolC cannot be produced. These results suggest that salicylate can induce much higher burden in the resistant strain (MarA + ) than in the susceptible strain (MarA -), and this burden is mainly contributed by the AcrAB-TolC efflux pump.
Salicylate accelerates competitive exclusion of resistant bacteria
We next sought to test whether using salicylate to increase the relative cost in the resistant strain (MarA + ) accelerates its exclusion in competitive environments. Since we found AcrAB-TolC to be largely responsible for the salicylate induced fitness cost, we first measured competitive exclusion between AcrBand MarA + . Using an AcrBstrain with genomically integrated sfgfp, we measured the fraction of AcrBand MarA + cells by flow cytometry and the growth of the competition culture using a plate reader.
In the absence of salicylate, small differences in growth rates are enough to allow the susceptible strain AcrBto out compete the resistant strain MarA + , although the exclusion effect is not large (Fig. 3a) . When the salicylate dosage was raised to 0.6 mM, the fraction of AcrBcells increased because salicylate reduces the growth of the resistant strain MarA + without imposing a significant impact on the susceptible strain AcrB - (Fig. 3b) . This difference is further magnified at higher levels of salicylate exposure (Fig. 3c) .
To predict the competition dynamics between strains in different concentration of salicylate, we employed a mathematical model that we fit to the single-species growth rate (μ) and carrying capacity (A) data and used it to predict two-species competition under various salicylate conditions. The growth rates and carrying capacities calculated from single culture growth curves fit using the Gompertz model were applied to a Lotka-Volterra model for competitive growth (Eqs. 2-3) . The model shows good agreement with the experimental data in the dynamics of both growth and the population fraction for each strain (Fig. 3) . We observed similar effects with salicylate when competing WT with AcrBand MarA - (Fig.  S8 ). However, competition between WT and MarA + did not lead to competitive exclusion. Since salicylate can significantly decrease bacterial growth (Fig. 2b) , we verified that our results were not an artifact of differences in growth rate by calculating the selection coefficients during competition between WT and all mutants under salicylate exposure (Fig. S9 ). The selection coefficient takes into account growth differences at higher salicylate concentrations (30) . We observed similar trends in selection coefficients and results with cell counts, where AcrBand MarAhave significantly higher finesses compared with WT at high concentrations of salicylate.
Reducing population fraction of resistant cells increases susceptibility to antibiotic exposure
To study the impact of the fraction of resistant strains on antibiotic resistance of a population, we subjected mixed populations with different proportions of susceptible (AcrB -) and resistant (MarA + ) strains to a lethal dose of carbenicillin (50 ߤ g/mL) for four hours and then measured the optical density and colony-forming units (CFU). The results show that carbenicillin resistance is directly related to the fraction of MarA + cells in the culture (Fig. 4) . We found similar results in mixed populations with MarA + and MarA - (Fig. S10) and MarA + and WT (Fig. S11c ), but not in populations with AcrBand WT or MarAand WT (Fig. S11a-b ). Decreasing the proportion of MarA + can significantly reduce the antibiotic resistance of the population. This result supports our hypothesis that antibiotic resistance levels decrease when a susceptible strain out-competes a resistant strain. 
Modelling population shifts under salicylate treatment
In the real-world environment, specific mutants may only constitute a small proportion of cells.
To study the population dynamics starting from a very small initial proportion of the susceptible strain, we next used the Lotka-Volterra model to make predictions about the effects of salicylate exposure on mixed populations of AcrBand MarA + (Fig. 5 ).
We simulated competitive exclusion by starting with various initial proportions of the susceptible strain AcrBand applying the model over the course of 60 generations (approximately 1 week in real time (7) ). The model predicts that resistant bacteria (MarA + ) will be out competed by AcrBmuch more rapidly with salicylate exposure than under conditions without salicylate. For example, if the susceptible strain AcrBinitially comprises 0.01% of the population, after 60 generations more than 30%, 80%, and 99% of MarA + is excluded in the presence of 0.3 mM, 0.6 mM, and 5 mM salicylate, respectively. These results are in stark contrast to the conditions without salicylate, where less than 5% of the MarA + can be out-competed by AcrBwith the same initial composition. The model predicts that AcrBcan outgrow MarA + and that salicylate accelerates this process, shifting the population towards antibiotic susceptible strains. 
Conclusions
Antibiotic resistance mechanisms frequently impose a significant fitness cost, suggesting the potential for competitive exclusion of resistant strains. However, this process is usually slow due to downregulation of the resistance machinery in the absence of inducers. One study combining mathematical modeling and experimental data predicted that it would take approximately 1.5 years to reverse tetracycline resistance by replacing 99.9% of the cells carrying the tetA resistance gene (7) . However, in the natural environment, bacteria commonly interact with other chemicals that could potentially induce expression of resistance genes. Costs imposed by induction could bias population composition.
In this study, we sought to unravel the impact of salicylate exposure on MarA-mediated resistance cost. We establish a mathematical model to predict the population dynamics under different levels of salicylate exposure and extended this to different initial population percentages. We found that salicylate imposes a higher cost in MarA-mediated resistant strains (MarA + ) than in susceptible (MarAand AcrB -) strains. Competition assays between MarA + and AcrBshowed a positive correlation between salicylate concentration and the relative fitness cost. This suggests that with higher salicylate induction, the relative fitness cost of resistant strains will increase, accelerating their competitive exclusion. Mathematical modelling also predicted mixed population dynamics from single strain growth parameters, and confirmed the effectiveness of salicylate exposure on accelerating the population bias towards susceptible strains. The resulting lower proportion of resistant cells in the population leads to greater lethality to carbenicillin. We further explored the origin of salicylate-mediated cost, and found that the AcrAB-TolC efflux pump contributes to escalated fitness cost in MarA-mediated resistant strains.
Other factors that might affect competitive exclusion include the effective concentrations of salicylate and other environmental chemicals. The physiological concentrations of salicylate in human circulating plasma have been measured and vary between 0.1 μ M to 0.5 mM (15) overlapping with values we tested here (Fig. 5 ). Furthermore, MarA and AcrAB are also involved in resistance to many environmental chemicals beyond antibiotics. Further research may enable understanding of the interplay between salicylate and other chemicals and their combinatorial effects.
Our study indicates the potential for important interaction effects between environmental chemicals and population composition. Understanding the interplay between environmental chemicals and the cost of resistance may help to explain and predict the population dynamics of resistant bacteria in the environment.
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